CORC

在结果中检索

CORC

浏览/检索结果: 共11条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy 期刊论文
NUCLEAR FUSION, 2022, 卷号: 62
作者:  Fenstermacher, M. E.;  Abbate, J.;  Abe, S.;  Abrams, T.;  Adams, M.
收藏  |  浏览/下载：41/0  |  提交时间：2022/12/23
DIII-D research towards establishing the scientific basis for future fusion reactors 期刊论文
NUCLEAR FUSION, 2019, 卷号: 59
作者:  Petty, C. C.;  Abadie, L.;  Abrams, T. W.;  Ahn, J.;  Akiyama, T.
收藏  |  浏览/下载：92/0  |  提交时间：2019/12/02
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials 期刊论文
2019, 卷号: 393, 期号: 10179, 页码: 1440-1452
作者:  Boddington, C.;  Bradley, R.;  Braybrooke, J.;  Burrett, J.;  Clarke, M.
收藏  |  浏览/下载：46/0  |  提交时间：2020/01/03
Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. 期刊论文
ANNALS OF ONCOLOGY, 2018, 卷号: 29, 期号: 1
作者:  Dubsky, P.;  Curigliano, G.;  Burstein, H. J.;  Winer, E. P.;  Gnant, M.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) 期刊论文
2018, 卷号: 29, 期号: 8, 页码: 1634-1657
作者:  Cardoso, F.;  Senkus, E.;  Costa, A.;  Papadopoulos, E.;  Aapro, M.
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials 期刊论文
2018, 卷号: 19, 期号: 1, 页码: 27-39
作者:  Alberro, J. A.;  Ballester, B.;  Deulofeu, P.;  Fabregas, R.;  Fraile, M.
收藏  |  浏览/下载：48/0  |  提交时间：2020/01/03
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 期刊论文
ANNALS OF ONCOLOGY, 2017, 卷号: 28, 期号: 8
作者:  Curigliano, G.;  Burstein, H. J.;  Winer, E. P.;  Gnant, M.;  Dubsky, P.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Phase III, randomized, double-blind, placebo-controlled study of ribociclib (LEE011) in combination with either tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with HR+, HER2-advanced breast cancer (aBC): MONALEESA-7 期刊论文
Journal of Clinical Oncology, 2015, 卷号: 33
作者:  Tripathy D., Bardia A., Hurvitz S.A., Harbeck N., Colleoni M., Franke F.A., Chow L.W.C., Im S.-A., Shao Z., Keyserlingk J.R., Soler L.M., Horan M., Dhuria S.V., Hughes G., Lu Y.-S.
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/19
MONALEESA-7: a phase III, randomized, double-blind, placebo-controlled study of ribociclib (LEE011) combined with standard first-line endocrine therapy (ET) for the treatment of premenopausal women with HR+, HER2-advanced breast cancer (aBC) 会议论文
作者:  Im, S. -A.;  Chow, L.;  Shao, Z.;  Tripathy, D.;  Bardia, A.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) 期刊论文
2014, 卷号: 25, 期号: 10, 页码: 1871-1888
作者:  Cardoso, F.;  Costa, A.;  Norton, L.;  Senkus, E.;  Aapro, M.
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace